Author details

Full Name

Amy Ziober

Affiliation

Hospital of the University of Pennsylvania

ORCID

Career Start Year

1995

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35521912	Hepatic Macrophage Types Cluster with Disease Etiology in Chronic Liver Disease and Differ Compared to Normal Liver: Implications for Their Biologic and Diagnostic Role.	Int J Surg Pathol	2023
33582751	Ionized Calcium Binding Adaptor Molecule 1 (IBA1).	Am J Clin Pathol	2021
31836680	Breast Cancer <sup>18</sup>F-ISO-1 Uptake as a Marker of Proliferation Status.	J Nucl Med	2020
30383612	Potential Diagnostic Pitfalls in Evaluating Immunohistochemistry for Cervical Myofibroblastomas.	Int J Gynecol Pathol	2019
31815646	Immune landscapes associated with different glioblastoma molecular subtypes.	Acta Neuropathol Commun	2019
28576927	Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells.	Cancer Discov	2017
26110513	Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer.	J Magn Reson Imaging	2016
24394305	Expression of Notch signaling components in cutaneous foreign body and sarcoidal granulomas and fusing macrophages.	Am J Dermatopathol	2014
25193277	Mesothelin expression is associated with poor outcomes in breast cancer.	Breast Cancer Res Treat	2014
24860692	Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma.	Exp Hematol Oncol	2014
22588642	Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes.	Laryngoscope	2013
23690119	Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma.	Am J Clin Pathol	2013
23722510	Expression of SALL4 and SF-1 in gonadoblastoma: useful markers in the identification of the invasive germ cell component.	Int J Gynecol Pathol	2013
23791764	Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.	Ann Diagn Pathol	2013
23552384	Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP).	Am J Surg Pathol	2013
23218904	Malignant tumors with clear cell morphology: a comparative immunohistochemical study with renal cell carcinoma antibody, Pax8, steroidogenic factor 1, and brachyury.	Ann Diagn Pathol	2013
22945475	H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer.	Dig Dis Sci	2013
23060304	Expression of parafibromin in clear cell papillary renal cell carcinoma.	Appl Immunohistochem Mol Morphol	2013
23142018	The expression of heterochromatin protein 1Î±/Î² in the kidney tumors: a microarray immunohistochemical study.	Ann Diagn Pathol	2013
22832114	SALL4 and SF-1 are sensitive and specific markers for distinguishing granulosa cell tumors from yolk sac tumors.	Int J Surg Pathol	2013
22898056	Role of carbonic anhydrase IX, Î±-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.	Ann Diagn Pathol	2013
22672805	Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas.	Ann Diagn Pathol	2013
22553814	The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms.	Appl Immunohistochem Mol Morphol	2012
22826786	A case of primary clear cell hepatocellular carcinoma in a non-cirrhotic liver: an immunohistochemical and ultrastructural study.	Rare Tumors	2012
20701444	Is gene expression profiling of head and neck cancers ready for the clinic?	Biomark Med	2010
17902150	Lab-on-a-chip for oral cancer screening and diagnosis.	Head Neck	2008
17996485	Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.	Oral Oncol	2008
16649214	The extracellular matrix in oral squamous cell carcinoma: friend or foe?	Head Neck	2006
17062667	Identification of a gene signature for rapid screening of oral squamous cell carcinoma.	Clin Cancer Res	2006
15963983	Suppression of laminin-5 expression leads to increased motility, tumorigenicity, and invasion.	Exp Cell Res	2005
15091212	Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.	Laryngoscope	2004
14508824	c-Met expression in tall cell variant papillary carcinoma of the thyroid.	Cancer	2003
12439174	Integrins in head and neck squamous cell carcinoma invasion.	Laryngoscope	2002
11802012	Tumor deposition of laminin-5 and the relationship with perineural invasion.	Laryngoscope	2001
9224951	Characterization and sequence of an additional 15-lipoxygenase transcript and of the human gene.	Biochim Biophys Acta	1997
7883980	Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter.	J Clin Invest	1995

1 - 36 of 36

Kris Ylaya

Center for Cancer Research, National Cancer Institute

Career Start Year 2008

Number of shared co-authors 0

Pinaki Bose

Cumming School of Medicine, University of Calgary

Career Start Year 2008

Number of shared co-authors 0

Joaquin J Garcia

Mayo Clinic

Career Start Year 2006

Number of shared co-authors 1

Andrew H Beck

Beth Israel Deaconess Medical Center, Harvard Medical School

Career Start Year 2004

Number of shared co-authors 0

Sabrina Daniela da Silva

Jewish General Hospital

Career Start Year 2004

Number of shared co-authors 0

Simion I Chiosea

University of Pittsburgh

Career Start Year 2003

Number of shared co-authors 1

Michelle D Williams

The University of Texas M. D. Anderson Cancer Center

Career Start Year 2001

Number of shared co-authors 1

Christopher J Howlett

Western University

Career Start Year 1999

Number of shared co-authors 0

Sang Yong Song

Center for Nanophase Materials Sciences, Oak Ridge National Laboratory

Career Start Year 1995

Number of shared co-authors 0

Paulette Mhawech-Fauceglia

University of Southern California

Career Start Year 1995

Number of shared co-authors 0

Bhaskar Kallakury

Georgetown University

Career Start Year 1993

Number of shared co-authors 0

Mark W Lingen

University of Chicago Pritzker School of Medicine

Career Start Year 1993

Number of shared co-authors 0

Sarah M Dry

Jonsson Comprehensive Cancer Center, University of California los angeles

Career Start Year 1992

Number of shared co-authors 0

Holger Moch

University Hospital Zurich

Career Start Year 1991

Number of shared co-authors 0

Bhuvanesh Singh

Memorial Sloan Kettering Cancer Center

Career Start Year 1991

Number of shared co-authors 0

Fredrik Pont??n

Uppsala University

Career Start Year 1991

Number of shared co-authors 0

Guido Sauter

Institute of Pathology, University Medical Center Hamburg-Eppendorf

Career Start Year 1990

Number of shared co-authors 0

Thomas J Giordano

University of Michigan ann arbor

Career Start Year 1989

Number of shared co-authors 2

Juan P Palazzo

Thomas Jefferson University Hospital

Career Start Year 1988

Number of shared co-authors 0

Stephen M Hewitt

Center for Cancer Research, National Cancer Institute

Career Start Year 1988

Number of shared co-authors 0

Christina S Kong

Stanford University School of Medicine

Career Start Year 1988

Number of shared co-authors 0

Silvano Bosari

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Career Start Year 1986

Number of shared co-authors 0

Wendell G Yarbrough

University of North Carolina at Chapel Hill

Career Start Year 1986

Number of shared co-authors 0

Ossama Tawfik

University of Kansas

Career Start Year 1985

Number of shared co-authors 0

Jahn M Nesland

The Norwegian Radium Hospital, Oslo University Hospital

Career Start Year 1980

Number of shared co-authors 0

David L Rimm

Yale University School of Medicine

Career Start Year 1980

Number of shared co-authors 0

Adel K El-Naggar

MD Anderson Cancer Center

Career Start Year 1980

Number of shared co-authors 1

Bernard T??tu

Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)

Career Start Year 1979

Number of shared co-authors 0

Bogdan Czerniak

University of Texas MD Anderson Cancer Center

Career Start Year 1975

Number of shared co-authors 1

Jeffrey S Ross

Foundation Medicine

Career Start Year 1974

Number of shared co-authors 0

row(s) 1 - 30 of 30

Brian M Feldman

Co-authored papers 7

Stephen Y Lai

The University of Texas MD Anderson Cancer Center

Co-authored papers 2

E Sigal

Institute of Biochemistry & Cell Biology

Co-authored papers 2

Noam A Cohen

Co-authored papers 2

Carl H June

University of Pennsylvania Department of Pathology & Laboratory Medicine

Co-authored papers 2

Gregory P Way

Broad Institute of MIT and Harvard

Co-authored papers 1

Yingtao Bi

Foundational Immunology, AbbVie Cambridge Research Center

Co-authored papers 1

Sharmistha Pal

Dana-Farber Cancer Institute

Co-authored papers 1

Donald M O'Rourke

Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania

Co-authored papers 1

Maria Martinez-Lage

Massachusetts General Hospital

Co-authored papers 1

Zubair W Baloch

Co-authored papers 1

Jeffrey P Greenfield

Weill Cornell Medical Center, NewYork Presbyterian Hospital

Co-authored papers 1

Bert W O'Malley

Center for Coregulator Research, Baylor College of Medicine

Co-authored papers 1

Josephine Haller

University of Pennsylvania School of Medicine

Co-authored papers 1

Ilya M Nasrallah

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 1

Casey S Greene

Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine

Co-authored papers 1

Rachel E Yan

Weill Cornell College of Medicine

Co-authored papers 1

Aivi T Nguyen

Mayo Clinic Rochester

Co-authored papers 1

Manoj Kandpal

Center for Clinical and Translational Science, Rockefeller University

Co-authored papers 1

Ramana V Davuluri

The Wistar Institute